Moringa oleifera Lam., commonly called the drumstick tree or horseradish tree, is an accepted species in the family Moringaceae. Kew records its native range as northeastern Pakistan to northwestern India, while the Ayurvedic Pharmacopoeia of India describes it as a small or medium-sized tree found in the sub-Himalayan tract and widely cultivated in India. Its leaves and immature pods are familiar foods, and several plant parts are separately recognized as Ayurvedic drugs under the name Shigru.

The plant part matters. The leaf, seed, root bark, and stem bark are not interchangeable: each has its own pharmacopoeial identity, sensory qualities, actions, dose conventions, and safety considerations. Most commercial powders and nutrition discussions concern the leaf, whereas classical medicinal preparations may specify another part. A label that says only “moringa” is therefore less informative than one that identifies the botanical name, plant part, and preparation.

Moringa is nutrient-rich, but the popular “superfood” label should not be treated as a therapeutic claim. Food composition varies with cultivar, soil, leaf age, climate, drying, and storage. Human trials have also used different powders, foods, extracts, and doses, so results from one preparation cannot automatically be transferred to another.

Nutritional Composition of Moringa Leaf Powder

Dried leaf powder concentrates nutrients by removing most of the water, but published values differ substantially between samples. The table below reproduces the composition of one analysed leaf-powder sample rather than presenting universal values for every moringa product.

These figures illustrate why serving size is essential. A tablespoon-scale portion supplies only a small fraction of the nutrients listed per 100 g. Comparisons such as “many times more calcium than milk” or “several times more vitamin C than oranges” commonly mix dried powder with water-rich fresh foods and ignore realistic portions. Moringa can contribute protein, fibre, carotenoids, and micronutrients, but it does not replace a varied diet or a prescribed treatment for nutritional deficiency.

Principal Phytochemicals

Moringa leaves contain several chemical groups that are active in laboratory systems. Their presence helps explain the plant’s pharmacological interest, but a compound detected in a leaf or extract is not by itself proof of a clinical effect at ordinary dietary doses.

• Glucosinolates and isothiocyanates: Glucomoringin is a characteristic glucosinolate; enzymatic hydrolysis can produce the isothiocyanate commonly called moringin.
• Flavonoids: Quercetin and kaempferol derivatives have been identified in leaf preparations, with amounts influenced by origin and processing.
• Phenolic acids: Chlorogenic, gallic, ferulic, and related acids occur in analysed plant extracts.
• Carotenoids and other constituents: Leaves also provide carotenoids, while sterols, saponins, tannins, and other compounds have been reported in different plant parts and extraction systems.

Antioxidant, anti-inflammatory, antimicrobial, glucose-related, and anticancer activities described in cell or animal models are useful for developing hypotheses. They should not be converted into disease-treatment promises without reproducible human outcomes, appropriate dosing, and safety data.

Human Evidence for Glucose, Lipids, and Blood Pressure

A 2025 meta-analysis evaluated randomized controlled trials of moringa supplementation in adults. It included nine trials, representing 12 study arms, with 341 participants in intervention groups and 308 in control groups. Preparations, doses, durations, and participant populations differed considerably.

The pooled analysis did not find statistically significant reductions in fasting blood glucose or HbA1c, and pooled lipid outcomes were also not significant. A modest reduction in diastolic blood pressure appeared in the main analysis but was lost in sensitivity testing. The certainty assigned to all evaluated cardiometabolic outcomes was very low because of risk of bias, heterogeneity, indirectness, and other methodological limitations.

Individual trials have sometimes reported favourable changes, including within-group glycaemic changes or short-term lipid responses. Those results do not establish moringa as a substitute for diabetes, cholesterol, or blood-pressure treatment. People with these conditions should continue prescribed care and use moringa, when appropriate, as food or as a supervised adjunct rather than as standalone therapy.

Ayurvedic Pharmacopoeial Profile

The Ayurvedic Pharmacopoeia of India gives distinct profiles for different parts of Shigru. While the leaf, seed, and root bark share a broadly pungent-bitter, heating, Kapha-Vata-pacifying character, they differ in the detail of their rasa, guna, and karma.

Thus, the official monographs describe the leaf, like the seed and root bark, as katu-tikta in rasa with ushna virya and katu vipaka, while the root bark additionally carries madhura rasa and sara guna. Ayurvedic selection should therefore consider the exact part, preparation, dose, constitution, digestive state, season, and clinical context.

Traditional Uses and Their Interpretation

The leaf monograph lists Ayurvedic therapeutic categories including shopha, gulma, krimiroga, medoroga, pliharoga, vidradhi, and galaganda. The seed and root-bark monographs contain overlapping but not identical indications. These Sanskrit categories arise from Ayurvedic diagnostic reasoning and should not be translated mechanically into modern biomedical diseases or used as proof that moringa treats a named contemporary condition.

Terms such as dipana and pachana describe classical actions relating to appetite and digestion; shophaghna denotes use in swelling; and medohara relates to the management of excess medas. Their application belongs within an individualized Ayurvedic assessment, not a one-herb protocol based only on a symptom or laboratory value.

Forms and Dosage

No universal dose can be assigned across foods, powders, juices, seeds, bark, and standardized extracts. The Ayurvedic Pharmacopoeia states that its doses are approximate adult guidance for clinicians, while modern clinical references note that trial doses of leaf preparations have varied widely.

Interactions, Pregnancy, and Adverse Effects

Safety disclaimer: Consult a qualified Ayurvedic practitioner and a healthcare provider before using medicinal-dose moringa, especially when pregnant or breastfeeding, treating a child, preparing for surgery, managing a chronic illness, or taking prescription medicines.

• Glucose- and blood-pressure-lowering medicines: Human effects are inconsistent, but monitoring is prudent because formulations and individual responses vary.
• Drug metabolism: Laboratory work indicates that some leaf extracts can inhibit CYP3A4 and P-glycoprotein. The clinical importance is uncertain, so people taking medicines with narrow therapeutic ranges should seek professional review.
• Pregnancy and breastfeeding: Safety of medicinal supplementation is not established. Concentrated supplements, particularly non-food parts, should be avoided unless specifically advised by the obstetric or paediatric care team.
• Adverse reactions: Digestive upset such as diarrhoea has occurred, and rare serious skin or allergic-type reactions have been reported. Stop the product and obtain urgent care for blistering rash, facial or tongue swelling, or breathing difficulty.

Moringa should not be used to reduce or stop prescribed diabetes, antihypertensive, lipid-lowering, thyroid, or other medication without the prescriber’s guidance.

Quality, Processing, and Storage

Drying method changes the phenolic, flavonoid, vitamin C, and antioxidant profile of moringa leaves, so “raw,” “shade-dried,” and heat-processed powders are not chemically identical. Store leaf powder in a tightly closed container protected from heat, moisture, light, and prolonged air exposure. Discard products with dampness, mould, abnormal odour, or damaged packaging.

Choose products that identify Moringa oleifera, state the plant part, provide batch and expiry information, and are tested for identity, microbial contamination, pesticides, and permitted limits of lead, arsenic, and other heavy metals. Pharmacopoeial quality control concerns authenticity and purity; it does not guarantee that a supplement will produce a particular clinical outcome.

Where Moringa Fits

Moringa leaves are a useful food ingredient, and a concentrated powder can add modest amounts of protein, fibre, carotenoids, and selected micronutrients. Ayurveda recognizes Shigru as a part-specific medicinal substance rather than a single interchangeable remedy. Current human data do not justify presenting moringa as a standalone treatment for diabetes, dyslipidaemia, hypertension, inflammation, infection, or cancer. Its most defensible place is as food or a carefully selected adjunct used with attention to plant part, preparation, dose, product quality, medicines, and individual constitution.

References

1. Powo (powo.science.kew.org)
2. Ayurvedic Pharmacopoeia of India
3. Ayurvedic Pharmacopoeia of India
4. Mdpi (mdpi.com)
5. Moringa oleifera: An Updated Comprehensive Review of Its Pharmacological Activities, Ethnomedicinal, Phytopharmaceutical Formulation, Clinical, Phytochemical, and Toxicological Aspects (2023), PubMed Central
6. Mdpi (mdpi.com)
7. Drugs (drugs.com)
8. Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4 (2008), PubMed Central
9. Drying alters the phenolic constituents, antioxidant properties, α-amylase, and α-glucosidase inhibitory properties of Moringa (Moringa oleifera) leaf (2018), PubMed Central
10. Ultrasonography vs computed tomography for stone size (2017), PubMed